China Universal Asset Management Company’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
9,985
+73
| +0.7% | +$825 | 0.01% | 356 |
|
|
2025
Q1 | $114K | Sell |
9,912
-417
| -4% | -$4.81K | 0.01% | 351 |
|
|
2024
Q4 | $87.5K | Buy |
10,329
+2,043
| +25% | +$17.3K | 0.01% | 408 |
|
|
2024
Q3 | $96K | Buy |
8,286
+3,328
| +67% | +$38.5K | 0.01% | 358 |
|
|
2024
Q2 | $58.4K | Sell |
4,958
-3,066
| -38% | -$36.1K | 0.01% | 346 |
|
|
2024
Q1 | $95.2K | Buy |
8,024
+4,043
| +102% | +$48K | 0.01% | 378 |
|
|
2023
Q4 | $48.8K | Buy |
+3,981
| New | +$48.8K | 0.01% | 371 |
|
|
2022
Q4 | – | Sell |
-230
| Closed | -$3K | – | 424 |
|
|
2022
Q3 | $3K | Buy |
+230
| New | +$3K | ﹤0.01% | 328 |
|